Literature DB >> 9166784

Investigation of membrane disruption in the reaction catalyzed by cholesterol oxidase.

K B Ghoshroy1, W Zhu, N S Sampson.   

Abstract

Dye leakage experiments were undertaken to investigate the membrane disruption properties of cholesterol oxidase. Inspection of the X-ray crystal structures of cholesterol oxidase suggested that an active-site "lid" opens in order to bind substrate [Li, J., Vrielink, A., Brick, P., & Blow, D. M. (1993) Biochemistry 32, 11507-11515]. We tested whether the interaction of the putative active-site lid with the membrane was sufficiently disruptive of the membrane structure to cause leakage or lysis of the cell membrane. Vesicles (100 nm) composed of egg phosphatidylcholine, 2-palmitoyl-3-oleoyl-1-sn-phosphatidylethanolamine, and 2-palmitoyl-3-oleoyl-1-sn-phosphatidylcholine were used in this study to mimic biomembranes. To separate the effects of membrane binding from conversion of cholesterol to cholest-4-en-3-one, the active-site mutant E361Q was utilized. In the reaction catalyzed by E361Q, isomerization of the cholest-5-en-3-one intermediate is suppressed and cholest-5-en-3-one is the major product isolated. Furthermore, E361Q produces cholest-5-en-3-one 20-fold more slowly than wild type produces cholest-4-en-3-one from cholesterol. Wild-type and E361Q cholesterol oxidases bind to vesicles with an apparent K(D) of approximately 25 microM, as measured by quenching of intrinsic tryptophan fluorescence, irrespective of headgroup size and cholesterol content. Membrane disruption was measured by leakage of the encapsulated marker carboxyfluorescein. Leakage was observed with cholesterol-containing vesicles and wild-type enzyme only; the rate of leakage was dependent on the rate of cholest-4-en-3-one production. E361Q did not induce membrane disruption, regardless of vesicle type tested. Thus, binding of cholesterol oxidase to the membrane and partitioning of cholesterol into the active site does not sufficiently perturb the bilayer to cause leakage of vesicle contents. Formation of the product cholest-4-en-3-one, however, does increase membrane permeability. Expansion of the lipid bilayer upon conversion of cholesterol to cholest-4-en-3-one is the likely cause of this increased permeability.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9166784     DOI: 10.1021/bi962190p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Antifungal tradecraft by cholesterol oxidase.

Authors:  Natasha M Nesbitt; Nicole S Sampson
Journal:  Chem Biol       Date:  2007-03

2.  Allosteric inhibition of individual enzyme molecules trapped in lipid vesicles.

Authors:  Hubert M Piwonski; Mila Goomanovsky; David Bensimon; Amnon Horovitz; Gilad Haran
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-04       Impact factor: 11.205

3.  Alzheimer disease beta-amyloid activity mimics cholesterol oxidase.

Authors:  Luigi Puglielli; Avi L Friedlich; Kenneth D R Setchell; Seiichi Nagano; Carlos Opazo; Robert A Cherny; Kevin J Barnham; John D Wade; Simon Melov; Dora M Kovacs; Ashley I Bush
Journal:  J Clin Invest       Date:  2005-08-25       Impact factor: 14.808

Review 4.  Cholesterol oxidase: physiological functions.

Authors:  Joseph Kreit; Nicole S Sampson
Journal:  FEBS J       Date:  2009-10-16       Impact factor: 5.542

Review 5.  Cholesterol homeostasis and the escape tendency (activity) of plasma membrane cholesterol.

Authors:  Yvonne Lange; Theodore L Steck
Journal:  Prog Lipid Res       Date:  2008-03-29       Impact factor: 16.195

6.  Method for measuring the unbinding energy of strongly-bound membrane-associated proteins.

Authors:  Elisa La Bauve; Briana C Vernon; Dongmei Ye; David M Rogers; Cathryn M Siegrist; Bryan D Carson; Susan B Rempe; Aihua Zheng; Margaret Kielian; Andrew P Shreve; Michael S Kent
Journal:  Biochim Biophys Acta       Date:  2016-07-15

Review 7.  Catabolism and biotechnological applications of cholesterol degrading bacteria.

Authors:  J L García; I Uhía; B Galán
Journal:  Microb Biotechnol       Date:  2012-02-07       Impact factor: 5.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.